SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Zynerba Pharmaceuticals Q1 EPS $(0.53) Misses $(0.50) Estimate

Zynerba Pharmaceuticals (NASDAQ:ZYNE) reported quarterly losses of $(0.530) per share which missed the analyst consensus estimate of $(0.500) by 6 percent. This is a 12.77 percent decrease over losses of $(0.470) per

Benzinga · 05/11/2020 11:02

Zynerba Pharmaceuticals (NASDAQ:ZYNE) reported quarterly losses of $(0.530) per share which missed the analyst consensus estimate of $(0.500) by 6 percent. This is a 12.77 percent decrease over losses of $(0.470) per share from the same period last year.